#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Familial haemophagocytic lymphohistiocytosis Necrotising myositis Gaucher's disease type I Pancreatic carcinoma Cold type haemolytic anaemia Undifferentiated sarcoma Biotinidase deficiency Fontan procedure Superficial vein thrombosis PIK3CA related overgrowth spectrum Stiff person syndrome Sarcoidosis Progressive supranuclear palsy Metachromatic leukodystrophy Huntington's disease More trials…

    Learn about Rare Diseases

    Pituitary-dependent Cushing’s syndrome – Treatment Medulloblastoma – Trials in Disease Familial haemophagocytic lymphohistiocytosis – Treatment Waldenstrom’s macroglobulinaemia recurrent – Basic Information Pemphigus – Basic Information Tuberous sclerosis complex – Trials in Disease Fabry’s disease – Life with Disease CADASIL – Treatment Glomerulonephritis rapidly progressive – Diagnostics Hypereosinophilic syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    SEPOFARSEN Encorafenib Dyp688 Pimecrolimus SARACATINIB Lasn01 Dasatinib Chlorphenamine Maleate Sodium Laurilsulfate Sodium Hydrogen Carbonate HRS 9531 Furosemide SEVABERTINIB Allopurinol Sodium Lurbinectedin Ondansetron Paroxetine Tetracycline Hydrochloride Risperidone Sulfur Hexafluoride More therapies…

    Learn about Your Condition

    Von Willebrand's disease Solitary fibrous tumour Mechanical ventilation Streptococcal infection Breast cancer stage II Hypertrophic scar Hypotonia Rhabdomyosarcoma Tonsillitis Nephrogenic anaemia Macular degeneration Bipolar I disorder Hyperhidrosis Vasospasm Meningioma malignant More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • A study to assess how SAR443820 is absorbed, broken down and removed by the body in healthy adult men

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • SAR443820
    The Netherlands

  • A study of TRV045 to test its effects on brain cell electrical activity in healthy adult men for epilepsy treatment development

    Not recruiting

    1 1
    Investigated Diseases:
    • Epilepsy
    Investigated Drugs:
    • TRV045
    The Netherlands

  • A study testing TRV045 for pain relief in healthy adults to understand its effects on nerve pain from diabetic peripheral neuropathy

    Not recruiting

    1 1
    Investigated Diseases:
    • Diabetic neuropathy
    Investigated Drugs:
    • TRV045
    The Netherlands

  • Testing Ulotaront Added to Antidepressants for Adults with Major Depressive Disorder Who Did Not Respond Well to Initial Treatment

    Not recruiting

    4 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Ulotaront
    • Citalopram
    • Venlafaxine
    Bulgaria Czechia Germany Hungary Poland Spain

  • A study testing the safety and how the body processes TAK-861 in children and teenagers aged 6 to 17 years with narcolepsy type 1

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Narcolepsy
    Investigated Drugs:
    • N-{(2S,3R)-4,4-Difluoro-1-(2-Hydroxy-2-Methylpropanoyl)-2-[(2,3′,5′-Trifluoro[1,1′-Biphenyl]-3-Yl)Methyl]Pyrrolidin-3-Yl}Ethanesulfonamide
    Italy

  • A Study of Donanemab in People With Early Symptomatic Alzheimer’s Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dementia
    • Mental disorder
    • Neurodegenerative disorder
    Investigated Drugs:
    • Florbetapir (18F)
    • Flortaucipir (18F)
    • Donanemab
    Poland Spain
Previous Page
1 … 82 83 84 85 86 … 142
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!